Surgical resection of recurrent gastrointestinal stromal tumor after interruption of long-term nilotinib therapy

BACKGROUND: Nilotinib inhibits the tyrosine kinase activities of ABL1/BCR-ABL1, KIT, and platelet-derived growth factor receptors (PDGFRs). The results of a phase III clinical trial indicated that nilotinib could not be recommended for broad use as first-line therapy for gastrointestinal stromal tum...

詳細記述

保存先:
書誌詳細
出版年:Surg Case Rep
主要な著者: Sugase, Takahito, Takahashi, Tsuyoshi, Ishikawa, Takashi, Ichikawa, Hiroshi, Kanda, Tatsuo, Hirota, Seiichi, Nakajima, Kiyokazu, Tanaka, Koji, Miyazaki, Yasuhiro, Makino, Tomoki, Kurokawa, Yukinori, Yamasaki, Makoto, Takiguchi, Shuji, Wakai, Toshifumi, Mori, Masaki, Doki, Yuichiro
フォーマット: Artigo
言語:Inglês
出版事項: Springer Berlin Heidelberg 2016
主題:
Case Report
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116018/
https://ncbi.nlm.nih.gov/pubmed/27864817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-016-0266-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料